SEC Form 4 · accession 0001140361-18-018962
NRC HEALTH · NRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin R Karas
Officer — SVP Finance, CFO, Treas & Secy · Director
Period of report
Apr 17, 2018
Accepted (ET)
Apr 18, 2018 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000070487
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class B Common StockF1 | Apr 17, 2018 | D | 2,355 | — | D | 0 | D | |
| Common StockF1 | Apr 17, 2018 | A | 2,355 | — | A | 16,160 | D | |
| Common StockF1,F2 | Apr 17, 2018 | A | 7,392 | — | A | 23,552 | D | |
| Common StockF1 | Apr 17, 2018 | F | 3,436 | $33.55 | D | 20,116 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $21.50 | Apr 17, 2018 | D | 4,400 | D | — | Jan 5, 2022 | Class B Common Stock | 4,400 | 0 | D |
| Employee Stock Option (right to buy)F2 | $27.13 | Apr 17, 2018 | D | 3,348 | D | — | Jan 7, 2023 | Class B Common Stock | 3,348 | 0 | D |
| Employee Stock Option (right to buy)F2 | $34.15 | Apr 17, 2018 | D | 489 | D | — | Jan 7, 2024 | Class B Common Stock | 489 | 0 | D |
| Employee Stock Option (right to buy)F2 | $35.48 | Apr 17, 2018 | D | 3,219 | D | — | Jan 6, 2025 | Class B Common Stock | 3,219 | 0 | D |
| Employee Stock Option (right to buy)F2 | $34.00 | Apr 17, 2018 | D | 3,410 | D | — | Jan 5, 2026 | Class B Common Stock | 3,410 | 0 | D |
| Employee Stock Option (right to buy)F2 | $40.54 | Apr 17, 2018 | D | 2,788 | D | — | Jan 4, 2027 | Class B Common Stock | 2,788 | 0 | D |
| Employee Stock Option (right to buy)F3 | $10.75 | holding | — | — | — | — | Jan 5, 2022 | Common Stock | 26,403 | 26,403 | D |
| Employee Stock Option (right to buy)F4 | $14.50 | holding | — | — | — | — | Jan 7, 2023 | Common Stock | 20,088 | 20,088 | D |
| Employee Stock Option (right to buy)F5 | $18.80 | holding | — | — | — | — | Jan 7, 2024 | Common Stock | 5,334 | 5,334 | D |
| Employee Stock Option (right to buy)F6 | $13.17 | holding | — | — | — | — | Jan 6, 2025 | Common Stock | 19,313 | 19,313 | D |
| Employee Stock Option (right to buy)F7 | $15.23 | holding | — | — | — | — | Jan 5, 2026 | Common Stock | 20,458 | 20,458 | D |
| Employee Stock Option (right to buy)F8 | $18.80 | holding | — | — | — | — | Jan 4, 2027 | Common Stock | 16,728 | 16,728 | D |
| Employee Stock Option (right to buy)F9 | $36.80 | holding | — | — | — | — | Jan 3, 2028 | Common Stock | 11,617 | 11,617 | D |
Explanation of responses
- F1On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization").
- F2Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding.
- F3This option became fully exercisable on January 5, 2017.
- F4This option became fully exercisable on January 7, 2018.
- F5This option becomes fully exercisable on January 7, 2019.
- F6This option becomes fully exercisable on January 6, 2020.
- F7This option becomes fully exercisable on January 5, 2021.
- F8This option becomes fully exercisable on January 4, 2022.
- F9This option becomes fully exercisable on January 3, 2023.